Fairfax Financial Holdings Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FRFGF research report →
Price Chart
About the company
Fairfax Financial Holdings Limited operates as a diversified holding company, primarily engaged in property and casualty insurance and reinsurance, in addition to providing investment management services. Its global reach spans the United States, Canada, Asia, and other international territories. The company organizes its operations across distinct segments: Insurance and Reinsurance, Run-off activities, and a portfolio of Non-Insurance Companies.
- CEO
- V. Prem Watsa
- IPO
- 2010
- Employees
- 47,040
- HQ
- Toronto, ON, CA
Get TickerSpark's AI analysis on FRFGF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $20.04B
- P/E
- 8.88
- PEG
- -1.80
- P/S
- 1.04
- P/B
- 1.35
- EV/EBITDA
- 6.11
- Div Yield
- 0.79%
- Gross Margin
- 69.91%
- Op Margin
- 16.77%
- Net Margin
- 11.53%
- ROE
- 15.98%
- ROIC
- 5.02%
Latest fiscal year · YoY change
- Revenue
- $28.45B-10.6%
- Gross Profit
- $28.45B-24.7%
- Op Income
- $5.64B
- Net Income
- $3.87B-11.6%
- EPS
- $237.35+37.0%
- OCF Growth
- +10236.8%
- FCF Growth
- +747.7%
- 52W High
- $15.50
- 52W Low
- $10.90
- 50D MA
- $12.58
- 200D MA
- $12.17
- Beta
- 0.84
- RSI (14)
- 100
- Avg Volume
- 13
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Fairfax reported a solid third quarter with strong underwriting, higher associate income, and continued growth in international insurance, while investment marks were pressured by rising rates.· November 4, 2026
- Operating income from insurance and reinsurance was $1.4 billion, up from $1.3 billion a year ago, with underwriting income of $524 million.
- Net earnings were $930 million in the quarter and $3 billion for the first nine months; book value per share reached $1,349, up 8.4% from year-end 2025 adjusted for the $15 dividend.
- Gross premiums written were $8.9 billion, up 9.3% year over year, led by international growth and still-disciplined underwriting in a softer market.
- Investment marks were negative in the quarter, with net losses on investments of $859 million driven mainly by bond mark-to-market losses from higher rates.
- Management highlighted several transactions, including the completed Eurolife sale, the Sleep Number and Andrew Peller acquisitions, and the selected bid for IDBI Bank, while also announcing the Boots deal with Wittington.
Fairfax said third-quarter operating income from insurance and reinsurance, adjusted to an undiscounted basis and before risk margin, was $1.4 billion, up from $1.3 billion in Q3 2025. Consolidated interest and dividend income was $669 million, up from $655 million a year ago; profits of associates were $378 million, up from $305 million; underwriting income was $524 million versus $540 million; and net losses on investments were $859 million compared with net gains of $426 million last year. Net earnings were $930 million for the quarter and $3 billion for the first nine months, while book value per share was $1,349, up 8.4% from year-end 2025 adjusted for the $15 dividend. Gross premiums written were $8.9 billion, up 9.3% year over year, with a combined ratio of 92.5% versus 92.0% a year ago and favorable reserve development of $156 million. Looking ahead, management said it expects full actuarial reserve reviews in the fourth quarter, and highlighted that Eurolife’s sale will add an approximate $200 million pre-tax gain in Q4; no formal next-quarter or full-year earnings guidance was provided.
Peter Clarke struck an upbeat but disciplined tone, emphasizing that Fairfax had another strong quarter despite a softening insurance market and higher rates hitting investment marks. He framed growth as coming mainly from international operations, not a broad market acceleration, and said the company remains focused on profitability rather than top-line targets. He also pointed to multiple strategic actions—Eurolife, IDBI Bank, Boots, Sleep Number, Andrew Peller, and Evergood—as evidence of continued capital deployment and flexibility.
Amy Sherk gave a detailed balance-sheet and transaction update. She said the company held $1.9 billion of cash and investments at the holding company, had an undrawn $2 billion revolving credit facility, and had an additional $2.4 billion at fair value in investments and market-traded non-insurance companies. She also said common shareholders’ equity rose to $26.9 billion from $26.3 billion at year-end 2025, the debt-to-total-capital ratio excluding non-insurance companies was 27.3%, and book value per share was $1,349.15 versus $1,260.19 at year-end 2025.
Analysts pressed on the IDBI Bank transaction, capital upstreaming, interest income trends, and whether stronger Q3 premium growth signaled a market shift. On IDBI, Peter Clarke declined to add details because the deal is still pending regulatory approval and directed listeners to prior disclosures. On capital allocation, he said the fourth quarter is the key period for assessing excess capital and that slower premium growth should leave more room for dividends upstream to the holding company. On interest income and growth, management said Q3 was usually light on dividends, fixed income remains very conservative and flexible, and the faster premium growth is largely being driven by international operations rather than a broad improvement in market conditions.
The quarter showed continued underwriting discipline, with a 92.5% combined ratio, $524 million of underwriting income, and $156 million of favorable reserve development. International insurance and reinsurance momentum was strong, with gross premiums up 27.1% and management saying those markets offer long-term growth potential. The investment portfolio also remains positioned for higher rates, with over $8.3 billion in cash and short-term bonds and management saying it is well placed even if rates move lower later.
Investment results were hurt by $859 million of net losses, mainly unrealized bond losses from higher interest rates, showing the quarter-to-quarter volatility management warned about. North American pricing is softening, especially in property and reinsurance, and several international units still had combined ratios above 100%, including Eurolife, Falcon Thailand, and Fairfirst in Sri Lanka. The IDBI transaction also remains exposed to regulatory approval and outside criticism, and management offered little additional color on that front.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 1.5%
- Shares Outstanding
- 1.29B
- Float Shares
- 20.02M
Our FRFGF coverage
Recent articles, reports, and earnings notes.
No research on FRFGF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FRFGF report →